Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
April 15, 2002
- Kyowa Hakko's Dacarbazine Approved for Hodgkin's Disease
April 15, 2002
- Ain Pharmaciez, Imagawa Yakuhin to Merge This November
April 15, 2002
- Asahi Kasei's Toledomin Shows Steady Growth in Sales
April 15, 2002
- Sugi Pharmacy: Sales Exceed \50 Bil.
April 15, 2002
- BUSINESS NEWS IN BRIEF
April 15, 2002
- OCT NEWS IN BREIF
April 15, 2002
- WEBSITE NEWS
April 15, 2002
- WORLD NEWS IN BRIEF
April 15, 2002
- CORPORATE ROUNDUP NEWS IN BRIEF
April 15, 2002
- The 122nd Anniversary Meeting of the Pharmaceutical Society of Japan
April 15, 2002
- Bills for Amended PAL Submitted to the Diet
April 15, 2002
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
April 15, 2002
- Korosho Details 5-year Plan for Policy Evaluation
April 15, 2002
- DIAGNOSTIC NEWS IN BRIEF
April 15, 2002
- Cost Calculation Method Needs Improvements: Budget Committee
April 15, 2002
- Korosho Prepares Decision Tree for Medical Devices
April 15, 2002
- Outline of Relief System for Victims of Tissue Engineering Products Recommended
April 15, 2002
- Terumo Latin America Established in Miami
April 15, 2002
- Plan of Reducing Subsidies to Public Corporations Approved
April 15, 2002
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…